Company Filing History:
Years Active: 2014
Title: Eva-Maria Schuermann: Innovator in Pestivirus Research
Introduction
Eva-Maria Schuermann is a notable inventor based in Tuebingen, Germany. She has made significant contributions to the field of veterinary medicine, particularly in the development of recombinant attenuated pestiviruses. Her work is crucial for advancing immunogenic compositions that can enhance animal health.
Latest Patents
Eva-Maria Schuermann holds a patent for an invention titled "Attenuated Pestivirus." This invention relates to recombinant attenuated pestiviruses, specifically focusing on recombinant attenuated Classical Swine Fever Virus (CSFV), Bovine Viral Diarrhea Virus (BVDV), or Border Disease Virus (BDV). The patent emphasizes that the recombinant attenuated pestivirus does not produce a dimeric Eglycoprotein. Additionally, it includes immunogenic compositions comprising such a pestivirus and outlines a method for attenuating a pestivirus through modifications to the Eglycoprotein.
Career Highlights
Eva-Maria Schuermann is associated with Boehringer Ingelheim Vetmedica GmbH, where she applies her expertise in veterinary virology. Her innovative approach has led to advancements in the prevention and treatment of viral infections in livestock.
Collaborations
Throughout her career, Eva-Maria has collaborated with esteemed colleagues, including Gregor Meyers and Birke Andrea Tews. These partnerships have fostered a collaborative environment that enhances research and development in veterinary medicine.
Conclusion
Eva-Maria Schuermann's contributions to the field of pestivirus research exemplify her dedication to improving animal health through innovation. Her patent and collaborative efforts highlight the importance of scientific advancements in veterinary medicine.